Programa de Pós-Graduação em Inovação Terapêutica (PPGIT)
Faculty
• Ana Cristina Lima Leite
Ph.D. in Interface Chimie Biologique from the Université de Montpellier I, France (1994).
Research line: Synthesis of drugs, production of blood products, peptide synthesis, bioactive organometallic chemistry, analysis, and control of medicines.
• Angela Luzia Branco Pinto Duarte
Ph.D. in Rheumatology from the Federal University of São Paulo (1989).
Line of research: Rheumatology, acting mainly on the following themes: rheumatoid arthritis, systemic lupus erythematosus, vasculitis, and biologicals.
• Antonio Carlos de Freitas
Ph.D. in Genetics from the Federal University of São Paulo (2000).
Research line: Vaccinology and experimental therapy applied to the control and treatment of diseases related to papillomavirus.
antonio.freitas@pesquisador.cnpq.br
• Artur Stamford da Silva
Ph.D. in Philosophy, Sociology and General Theory of Law from the Federal University of Pernambuco (2002).
Line of research: Legal decision and protection of intellectual property in products in the pharmaceutical chain.
artur.silva@ufpe.br, artur@stamford.pro.br
• César Augusto Souza de Andrade
Ph.D. in Materials Science from the Federal University of Pernambuco (2006).
Research line: Development and biological and physical-chemical analysis of nanostructured devices based on biomolecules; Controlled release systems.
• Claudio Gabriel Rodrigues
Ph.D. in Biological Sciences from the Federal University of Pernambuco (2006).
Research line: Activity and transport of biologically active molecules in protein nanopores.
• Dinaldo Cavalcanti de Oliveira
Ph.D. in Health Sciences from the Federal University of São Paulo (2006).
Research line: Medical clinic, Clinical cardiology, Hemodynamics and interventional cardiology.
• Ivan da Rocha Pitta
Docteur d'Etat es Sciences Pharmaceutiques by the Université Joseph-Fourier de Grenoble I, France (1973).
Research line: Planning and synthesis of drug candidate molecules.
• João Policarpo Rodrigues Lima
Ph.D. in Economics from the University of London, England (1988).
Research line: Applied Economics; Regional development; Northeast of Brazil; Productive arrangements; Local development and regional economy; Technological demands, trends, and perspectives of the pharmaceutical industry.
• Jose Lamartine Soares Sobrinho
Ph.D. in Pharmaceutical Sciences from the Federal University of Pernambuco (2009).
Line of research: Industrial technological development of medicines.
• Karina Perrelli Randau
Ph.D. in Pharmazeutische ChemiE from Ludiwig Maximilians Universität München (2006).
Research line: Chemistry of Natural products.
• Luiz Alberto Lira Soares
Ph.D. in Pharmaceutical Sciences from the Federal University of Rio Grande do Sul (2002)
Research line: Analytical, Technological, and Biological Development of Plant Species.
• Maira Galdino da Rocha Pitta
Ph.D. in Life and Health Sciences from the Université de la Méditerranée Aix-Marseille II (2009)
Research line: Immunogenetics and Drug Discovery.
• Marcelo Zaldini Hernandes
Ph.D. in Chemistry from the Federal University of Pernambuco (2001).
Research line: Development of molecular modeling software and applications in systems of biological interest.
• Maria Carolina Accioly Brelaz de Castro
Ph.D. in Therapeutic Innovation from the Federal University of Pernambuco (2013).
Research line: Development and evaluation of immunological biomarkers and vaccines in infectious and parasitic diseases
• Maria Danielly Lima de Oliveira
Ph.D. in Chemistry from the Federal University of Pernambuco (2008).
Research line: Biosensors, nanotechnology, and development of biodevices.
• Maria do Carmo Alves de Lima
Ph.D. in Organic Chemistry and Biochemistry from the Université de Paris VI, France (1995).
Research line: Pharmaceutical and medicinal chemistry; Drug planning and synthesis; Chemistry of natural products; Organic synthesis.
nenalima.mariadocarmo@gmail.com
• Moacyr Jesus Barreto de Melo Rêgo
Ph.D. in Therapeutic Innovation from UFPE (2011).
Research line: Glycobiology and Immunology of Chronic Diseases: Diagnosis, prognosis and therapeutic innovation
• Monica Felts De La Roca Soares
PhD in Pharmaceutical Science (2011)
Line of research: Industrial technological development of medicines.
• Pedro José Rolim Neto
PhD in Sciences Pharmaceutiques by the Université de Montpellier, France (1992).
Research line: Pre-clinical development of pharmaceutical forms for oral and parenteral administration.
• Tatiane Almeida de Menezes
PhD in Economics from the University of São Paulo (1999).
Research line: Health Economics
• Teresinha Gonçalves Da Silva
PhD in Biological Sciences from the Federal University of Pernambuco (2003).
Research line: Evaluation of the toxicological activity of drugs and bioactive molecules in biological systems.
• Valéria Pereira Hernandes
PhD in Cellular and Molecular Biology from Fundação Oswaldo Cruz (2003).
Line of research: Immune-cellular response and cytotoxicity in drug discovery and development.